David M. Urso
2022
In 2022, David M. Urso earned a total compensation of $1.7M as Chief Operating Officer and General Counsel at MEI Pharma, a 18% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $148,842 |
|---|---|
| Option Awards | $1,078,500 |
| Salary | $516,810 |
| Total | $1,744,152 |
Urso received $1.1M in option awards, accounting for 62% of the total pay in 2022.
Urso also received $148.8K in non-equity incentive plan and $516.8K in salary.
Rankings
In 2022, David M. Urso's compensation ranked 1,939th out of 5,501 executives tracked by ExecPay. In other words, Urso earned more than 64.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,939 out of 5,501 | 65th |
Division Manufacturing | 1,028 out of 2,980 | 66th |
Major group Chemicals And Allied Products | 436 out of 1,335 | 67th |
Industry group Drugs | 398 out of 1,238 | 68th |
Industry Pharmaceutical Preparations | 286 out of 892 | 68th |
Source: SEC filing on October 27, 2022.
Urso's colleagues
We found three more compensation records of executives who worked with David M. Urso at MEI Pharma in 2022.